Newsfeeds - Spark Newswire

1 minute read

Morgan Stanley Initiates Coverage On United Therapeutics with Overweight Rating, Announces Price Target of $288

October 11, 7:25 AM

Morgan Stanley analyst Terence Flynn initiates coverage on United Therapeutics (NASDAQ:UTHR) with a Overweight rating and announces Price Target of $288.

UTHR

1 minute read

United Therapeutics Stops Late-Stage Tyvaso Study In Lung Disease

By Vandana Singh

September 20, 10:58 AM

United Therapeutics Corp (NASDAQ:UTHR) has terminated the Phase 3 PERFECT study evaluating Tyvaso (treprostinil) Inhalation Solution for pulmonary hypertension associated with…

UTHR

1 minute read

United Therapeutics On Sept 20, Announced Termination Of Clinical Study Evaluating Tyvas Inhalation Solution For Treatment Of Pulmonary Hypertension

By Bill Haddad

September 20, 6:29 AM

-Reuters

UTHR

2 minute read

Legal
News

United Therapeutics Announced it Prevailed in Dry Powder Inhaler Patent Litigation vs Liquidia Technologies

By Charles Gross

August 31, 6:41 PM

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the United States District Court for the District of Delaware issued an opinion in the pending litigation concerning United Therapeutics' U.S. patents 9,593,066 (the '066 patent) and 10,716,793 (the '793 patent).

LQDT

1 minute read

Earnings

Earnings Outlook For United Therapeutics

By Benzinga Insights

August 2, 10:20 AM

United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement. Analysts estimate that United Therapeutics will report an earnings per share (EPS) of $4.12.

UTHR

2 minute read

Will Investors Notice Exciting Sign On United Therapeutics’s Chart?

By Benzinga Insights

June 10, 1:04 PM

If history is any guide, there may be good fortune ahead for shares of United Therapeutics (NASDAQ:UTHR). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

UTHR

2 minute read

Short Volatility Alert: United Therapeutics Corporation

By Christopher Sappo

May 26, 11:26 AM

On Wednesday, shares of United Therapeutics Corporation (NASDAQ: UTHR) experienced volatile short activity. After the activity, the stock price went up 4.31% to $228.39. The overall sentiment for UTHR has been Bullish.

UTHR